Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinicopathologic significance of putative stem cell marker, CD44 and CD133, in human gastric carcinoma.

Journal of surgical oncology - 1 Jun 2013

Chen Shi, Hou Jing-Hui, Feng Xing-Yu, Zhang Xiao-Shi, Zhou Zhi-Wei, Yun Jing-Ping, Chen Ying-Bo, Cai Mu-Yan

Abstract excerpt

BACKGROUND AND OBJECTIVES: CD44 and CD133 have been reported as putative stem cell markers. However, the clinicopathologic significance of CD44 and CD133 expression in patients with gastric carcinoma (GC) has not been clearly elucidated. METHODS: Immunohistochemistry (IHC) was performed to investigate the CD44 and CD133 expression in gastric carcinomas and normal mucosal tissues. Receiver operating characteristic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to AC133 Antigen
Share to Glycoproteins

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Hyaluronan Receptors

Share to Kaplan-Meier Estimate

Share to Neoplasm Grading

Share to Neoplastic Stem Cells

Share to ROC Curve

Share to Stomach Neoplasms

Source

Identifiers

PMID: 23609373
DOI: 10.1002/jso.23337

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinicopathologic significance of putative stem cell marker, CD44 and CD133, in human gastric carcinoma.PMID 23609373Read ↗

Clinicopathological and prognostic significance of cancer stem cell markers CD44 and CD133 in patients with gastric cancerSemantic proximity Read ↗

Polymorphisms of cancer stem cell marker gene CD133 are associated with susceptibility and prognosis of gastric cancer.Semantic proximity Read ↗

Identification of Gastric Cancer Stem Cells Using the Cell Surface Marker CD44Semantic proximity Read ↗

CD133+/CD166+ human gastric adenocarcinoma cells present the properties of neoplastic stem cells and emerge more malignant featuresSemantic proximity Read ↗

CD44v8-10 Is a Cancer-Specific Marker for Gastric Cancer Stem CellsSemantic proximity Read ↗

New emerging roles of CD133 in cancer stem cell: Signaling pathway and miRNA regulationSemantic proximity Read ↗

Identification of stem cell-related subtypes and risk scoring for gastric cancer based on stem genomic profilingSemantic proximity Read ↗

miRNAs expressed differently in cancer stem cells and cancer cells of human gastric cancer cell line MKN‐45Semantic proximity Read ↗

Comprehensive analysis of transcriptome data stemness indices identifies key genes for controlling cancer stem cell characteristics in gastric cancerSemantic proximity Read ↗

Analysis of the prognostic biomarkers associated with cancer stem cell characteristics and immune infiltration of Helicobacter pylori-induced gastric cancerSemantic proximity Read ↗

Prognostic Prediction Using a Stemness Index-Related Signature in a Cohort of Gastric CancerSemantic proximity Read ↗

Expression of stem cell markers nanog and PSCA in gastric cancer and its significanceSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.